IFRD1 Antibodies

Santa Cruz Biotechnology provides a broad selection of IFRD1 monoclonal antibodies for research applications. IFRD1 monoclonal antibodies are compatible with western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). IFRD1, or Interferon-related developmental regulator 1, plays a crucial role in cellular processes such as immune response regulation and cell differentiation. The involvement of IFRD1 in various signaling pathways highlights its significance in both normal physiology and disease states, making it a key target for research in immunology and cancer biology. Studying IFRD1 expression and interactions provides valuable insights into cellular mechanisms and potential therapeutic approaches. Researchers investigating IFRD1 can uncover new pathways and mechanisms related to immune system regulation and cellular development. Understanding IFRD1's role in disease progression helps identify potential therapeutic targets and biomarkers. IFRD1 monoclonal antibodies from Santa Cruz Biotechnology enable researchers worldwide to advance scientific understanding of immune system regulation and disease mechanisms.